Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POMALIDOMIDE for Brain neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where POMALIDOMIDE was used for Brain neoplasm malignant.

Most Reported Side Effects for POMALIDOMIDE

Side Effect Reports % Deaths Hosp.
Plasma cell myeloma 7,023 7.6% 3,048 1,311
Death 6,795 7.4% 6,792 495
Fatigue 6,530 7.1% 148 811
Pneumonia 5,792 6.3% 653 4,576
Off label use 3,845 4.2% 388 826
Diarrhoea 3,351 3.6% 140 720
White blood cell count decreased 3,328 3.6% 85 686
Neutropenia 3,029 3.3% 386 944
Rash 2,715 2.9% 47 273
Dyspnoea 2,543 2.8% 145 890
Neuropathy peripheral 2,382 2.6% 74 248
Constipation 2,374 2.6% 52 334
Asthenia 2,300 2.5% 117 715
Nausea 2,045 2.2% 100 362
Product dose omission issue 1,961 2.1% 7 174

Other Indications for POMALIDOMIDE

Plasma cell myeloma (81,096) Product used for unknown indication (4,764) Plasma cell myeloma recurrent (2,809) Plasma cell myeloma refractory (1,562) Plasma cell myeloma in remission (1,379) Amyloidosis (477) Off label use (434) Kaposi's sarcoma (268) Plasma cell leukaemia (209) Plasmacytoma (191)

Other Drugs Used for Brain neoplasm malignant

PROCARBAZINE (2,283) TEMOZOLOMIDE (2,202) BEVACIZUMAB (740) TRAMETINIB DIMETHYL SULFOXIDE (317) LOMUSTINE (291) THALIDOMIDE (195) DABRAFENIB (189) IVOSIDENIB (140) SELINEXOR (136) AVAPRITINIB (122)

Related Pages

POMALIDOMIDE Full Profile All Brain neoplasm malignant Drugs POMALIDOMIDE Demographics POMALIDOMIDE Timeline